Study shows people with Type 2 diabetes require ongoing and sustained clinical support

June 13, 2012

Research led by the University of Leicester concludes that people newly diagnosed with Type 2 diabetes need ongoing advice from GPs sustained over a number of years rather than a one-off session when they are first diagnosed.

Although a single programme for people with newly diagnosed shows sustained improvements in some illness beliefs at three years, there is no sustained difference in biomedical or lifestyle outcomes, finds the research published in BMJ.

The study, funded by Diabetes UK, was led by Professor Kamlesh Khunti, of the University of Leicester, and Professor Davies, of the University of Leicester and Leicester hospitals, with colleagues from the Leicester Diabetes Centre.

The authors state: ''In recent years, programmes to educate people with Type 2 diabetes about have become the focus of attention among and are advocated for people with the condition .Yet few established self management education programmes have reported long term effects of the intervention.''

The team analysed three year follow-up data of 731 patients from over 200 . Individuals newly diagnosed with Type 2 diabetes were randomised either to a one-day self-management education programme (DESMOND) or usual GP care. The results reveal that the significant benefits in the across four out of five seen at 12 months were sustained at three years. HbA1c levels at three years had decreased in both groups although the difference was not significant. The groups did not differ for the other biomedical and lifestyle outcomes and . Depression scores and did not differ at three years.

Professor Kamlesh Khunti at the University of Leicester, said: ''It demonstrates that these patients need care planning and ongoing structured education rather than a one-off programme when they are diagnosed – in order to see continued benefits with regard to lifestyle and biomedical outcomes.''

The authors believe that the DESMOND intervention at diagnosis is beneficial for psychosocial outcomes. The authors argue that ''although these benefits are important it remains uncertain at what stage, if ever, biomedical benefits emerge in people with newly diagnosed type 2 diabetes and whether in the longer term a relation between the two translates into more effective self management to maintain glycaemic control.'' Their previous evaluation showed that these programmes are cost-effective to implement in practice.

In conclusion, they believe that ''participants may need further education and ongoing support to successfully manage their condition and to achieve improvements to clinical outcomes and self management behaviours long term.''

Dr Iain Frame, Director of Research for Diabetes UK, said: "We welcome new research into structured education because we see structured education with a healthcare team as an important part of ensuring that people with diabetes have the tools to manage their own condition. This is why we continue to fund research into making sure it is as effective as possible to meet the needs of people with the condition."

In an accompanying editorial, Professor Frank Snoek, from the VU university medical center in the Netherlands, stated that various illness beliefs do not have equal relevance for maintaining acquired behaviour changes at a later stage and stressed the importance of glycaemic control for a population with . Professor Snoek suggested that ''we should focus again on the setting of appropriate targets by professionals who care for patients with diabetes and the patients themselves.''

Explore further: Doubts over long term impact of group education for diabetes patients

Related Stories

Doubts over long term impact of group education for diabetes patients

April 26, 2012
The benefits of a one-off group education programme for people with newly diagnosed type 2 diabetes are not sustained over the long term, concludes a study published on BMJ today.

Educational interventions appear to be effective for patients with poorly controlled diabetes

October 10, 2011
Three randomized controlled trials published Online First today in Archives of Internal Medicine examine the effectiveness of behavioral and educational interventions for patients with poorly controlled diabetes. All three ...

Study to examine impact of diabetes on life quality

July 12, 2011
(Medical Xpress) -- People living with Type 2 Diabetes are being recruited for a national online survey to understand how it affects their quality of life.

Recommended for you

Getting fat to 'talk' again could lower blood glucose and weight

August 22, 2017
Diabetes is a tough disease to manage. Oral medications, insulin shots, close monitoring of blood sugar, dietary changes and exercise can all factor into a person's treatment regimen. Now researchers are exploring a novel, ...

Biochemical 'fingerprints' reveal diabetes progression

August 21, 2017
Researchers from Umeå University in Sweden describe a new method to study biochemical changes that occur in the pancreas during the development of diabetes. The method, recently published in Scientific Reports, is based ...

In a nutshell: Walnuts activate brain region involved in appetite control

August 17, 2017
Packed with nutrients linked to better health, walnuts are also thought to discourage overeating by promoting feelings of fullness. Now, in a new brain imaging study, researchers at Beth Israel Deaconess Medical Center (BIDMC) ...

Smart mat detects early warning signs of foot ulcers

August 16, 2017
While completing his residency in anesthesiology at Massachusetts General Hospital in the mid-2000s, Jon Bloom saw his fair share of foot amputations among patients with diabetes. The culprit: infected foot ulcers.

The best place to treat type 1 diabetes might be just under your skin

August 14, 2017
A group of U of T researchers have demonstrated that the space under our skin might be an optimal location to treat type 1 diabetes (T1D).

New measure of insulin-making cells could gauge diabetes progression, treatment

August 10, 2017
Researchers at the University of Wisconsin-Madison have developed a new measurement for the volume and activity of beta cells, the source of the sugar-regulating hormone insulin.

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.